Raymond James & Associates’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-15,575
| Closed | -$1.06M | – | 3669 |
|
|
2019
Q3 | $1.06M | Buy |
15,575
+3,603
| +30% | +$244K | ﹤0.01% | 2173 |
|
|
2019
Q2 | $696K | Sell |
11,972
-4,086
| -25% | -$238K | ﹤0.01% | 2432 |
|
|
2019
Q1 | $1.13M | Buy |
16,058
+1,782
| +12% | +$125K | ﹤0.01% | 2129 |
|
|
2018
Q4 | $920K | Sell |
14,276
-844
| -6% | -$54.4K | ﹤0.01% | 2138 |
|
|
2018
Q3 | $1.06M | Buy |
15,120
+158
| +1% | +$11.1K | ﹤0.01% | 2221 |
|
|
2018
Q2 | $754K | Buy |
14,962
+624
| +4% | +$31.4K | ﹤0.01% | 2390 |
|
|
2018
Q1 | $449K | Buy |
14,338
+461
| +3% | +$14.4K | ﹤0.01% | 2623 |
|
|
2017
Q4 | $475K | Buy |
13,877
+764
| +6% | +$26.2K | ﹤0.01% | 2552 |
|
|
2017
Q3 | $421K | Buy |
13,113
+379
| +3% | +$12.2K | ﹤0.01% | 2574 |
|
|
2017
Q2 | $414K | Buy |
+12,734
| New | +$414K | ﹤0.01% | 2527 |
|
|
2015
Q4 | – | Sell |
-23,760
| Closed | -$503K | – | 2422 |
|
|
2015
Q3 | $503K | Buy |
23,760
+1,050
| +5% | +$22.2K | ﹤0.01% | 1917 |
|
|
2015
Q2 | $631K | Buy |
22,710
+6,110
| +37% | +$170K | ﹤0.01% | 1969 |
|
|
2015
Q1 | $507K | Buy |
+16,600
| New | +$507K | ﹤0.01% | 2032 |
|